These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6152262)

  • 1. Neuropeptides in dopamine-containing regions of the brain.
    Albanese A; Altavista MC
    Ital J Neurol Sci; 1984 Dec; 5(4):391-404. PubMed ID: 6152262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent discoveries on the function and plasticity of central dopamine pathways].
    Thibault D; Kortleven C; Fasano C; Dal Bo G; Trudeau LE
    Med Sci (Paris); 2010 Feb; 26(2):165-70. PubMed ID: 20188048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides in behavior and psychiatric syndromes: an overview.
    Barchas JD; Elliott GR
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():287-307. PubMed ID: 2873638
    [No Abstract]   [Full Text] [Related]  

  • 4. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease.
    Deutch AY
    J Neural Transm Gen Sect; 1993; 91(2-3):197-221. PubMed ID: 8099797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropeptides, neurotransmission and acupuncture].
    Ionescu-Tîrgoviţe C; Iufu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):241-8. PubMed ID: 6134326
    [No Abstract]   [Full Text] [Related]  

  • 6. [Structural and functional organization of the cerebral dopaminergic system].
    Barishpolets VV; Fedotova IuO; Sapronov NS
    Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon.
    Kalivas PW
    Neurosci Biobehav Rev; 1985; 9(4):573-87. PubMed ID: 2417173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid hypofunction in Parkinson's disease.
    Sandyk R; Gillman MA
    Med Hypotheses; 1985 Feb; 16(2):179-82. PubMed ID: 2581117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
    Schmauss C; Emrich HM
    Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of neuropeptides on neurotransmitter biochemistry in the CNS.
    Vaughan PF
    Cell Mol Biol; 1982; 28(4):369-82. PubMed ID: 6182996
    [No Abstract]   [Full Text] [Related]  

  • 11. Spinal and trigeminal mechanisms of nociception.
    Dubner R; Bennett GJ
    Annu Rev Neurosci; 1983; 6():381-418. PubMed ID: 6132587
    [No Abstract]   [Full Text] [Related]  

  • 12. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological aspects of centrally acting peptides.
    Renaud LP
    Int J Neurol; 1980; 14(2-4):210-20. PubMed ID: 6243044
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 15. Anatomy and physiology of the neuroendocrine arcuate nucleus.
    Chronwall BM
    Peptides; 1985; 6 Suppl 2():1-11. PubMed ID: 2417205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesocortical dopaminergic function and human cognition.
    Weinberger DR; Berman KF; Chase TN
    Ann N Y Acad Sci; 1988; 537():330-8. PubMed ID: 2974264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission.
    Rebec GV; Pierce RC
    Prog Neurobiol; 1994 Aug; 43(6):537-65. PubMed ID: 7816935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroendocrine correlations in the pathogenesis and pathology of Parkinson disease].
    Pinessi L; Sabbatini F; De Mattei M; Gentile S
    Minerva Med; 1984 Nov; 75(42):2539-42. PubMed ID: 6096765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray.
    Roychowdhury SM; Fields HL
    Neuroscience; 1996 Oct; 74(3):863-72. PubMed ID: 8884782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons.
    Beck KD
    Prog Neurobiol; 1994 Dec; 44(5):497-516. PubMed ID: 7886237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.